AU6518298A - Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient - Google Patents
Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredientInfo
- Publication number
- AU6518298A AU6518298A AU65182/98A AU6518298A AU6518298A AU 6518298 A AU6518298 A AU 6518298A AU 65182/98 A AU65182/98 A AU 65182/98A AU 6518298 A AU6518298 A AU 6518298A AU 6518298 A AU6518298 A AU 6518298A
- Authority
- AU
- Australia
- Prior art keywords
- novel
- active ingredient
- vaccines containing
- recombinant dna
- vectors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000013598 vector Substances 0.000 title 2
- 108020004414 DNA Proteins 0.000 title 1
- 108020004511 Recombinant DNA Proteins 0.000 title 1
- 239000004480 active ingredient Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9487597 | 1997-03-28 | ||
JP9-94875 | 1997-03-28 | ||
PCT/JP1998/001358 WO1998044093A1 (en) | 1997-03-28 | 1998-03-26 | Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6518298A true AU6518298A (en) | 1998-10-22 |
Family
ID=14122232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU65182/98A Abandoned AU6518298A (en) | 1997-03-28 | 1998-03-26 | Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP3924328B2 (en) |
AU (1) | AU6518298A (en) |
WO (1) | WO1998044093A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE253123T1 (en) * | 1991-08-26 | 2003-11-15 | Baxter Healthcare Sa | A RECOMBINANT BIRD POX VIRUS CONTAINING AN INTACT FPV-TK GENE |
AU729518B2 (en) * | 1995-06-07 | 2001-02-01 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
-
1998
- 1998-03-26 WO PCT/JP1998/001358 patent/WO1998044093A1/en active Application Filing
- 1998-03-26 JP JP54142298A patent/JP3924328B2/en not_active Expired - Lifetime
- 1998-03-26 AU AU65182/98A patent/AU6518298A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998044093A1 (en) | 1998-10-08 |
JP3924328B2 (en) | 2007-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1016218A1 (en) | Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv. | |
AU6443298A (en) | Self-assembling genes, vectors and uses thereof | |
AU1124499A (en) | Human papillomavirus vectors | |
AU4594996A (en) | Recombinant alphavirus vectors | |
IL195649A0 (en) | Compositions comprising anti-??v??3 recombinant human antibodies and nucleic acids encoding the same | |
ZA975943B (en) | Aqueous formulations of peptides. | |
IL128882A0 (en) | Viral vectors and their uses | |
HUP0000575A3 (en) | Novel formulation comprising budesonid as active indegredient | |
AU3423695A (en) | Novel sunscreens, photoprotective cosmetic compositions containing them and uses thereof | |
AU3119895A (en) | Recombinant virus vectors | |
AU6729198A (en) | Cosmetic preparations | |
GB9721909D0 (en) | Gene delivery vectors and their uses | |
AU3309997A (en) | Recombinant adeno-associated viral vectors | |
AU3423795A (en) | Novel sunscreens, photoprotective cosmetic compositions containing them and uses thereof | |
AU7077898A (en) | Recombinant vectors derived from adeno-associated virus suitable for gene therapy | |
HK1052436A1 (en) | Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same | |
PL337757A1 (en) | Novel lyposomic vectors of an active ingredient | |
AU634773B2 (en) | Spheroidin dna isolate and recombinant entomopoxvirus expression vectors | |
HUP9802587A3 (en) | Glucose-inducible recombinant viral vector, pharmaceutical composition containing it and cells transformed by this | |
GB2316681B (en) | Antigenically active proteins/polypeptides and coronavirus vaccines containing the same | |
AU3611495A (en) | Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating | |
AU6518298A (en) | Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient | |
AU8392698A (en) | Novel bacteriocins, transport and vector system and method of use thereof | |
IL144692A0 (en) | Insect viral vectors and uses thereof | |
AU6000500A (en) | Virus vectors and preparations and their uses |